Sponsored Links
| Study Shows Advanced Colorectal Cancer Patients Do Not Benefit From Adding Cetuximab To Standard Chemotherapy But Could Benefit From Treatment Breaks |
 |
 |
 |
| Medical News - Colorectal Cancer | |||
|
The targeted therapy cetuximab does not improve progression-free survival (PFS) or overall survival (OS) when added to standard chemotherapy as a first-line treatment for advanced colorectal cancer, according to the largest trial to date in advanced bowel cancer... Read more: Colorectal Cancer News From Medical News Today
|